Lupin
Dr Rajender Kamboj leads new drug discovery and development at Lupin. His expertise spans a wide spectrum: from drug discovery, licensing products and technologies and business development to mergers and acquisitions, research and corporate development activities. He holds more than 200 US patents, covering new molecular entities, products, the composition of matter, various therapeutic uses and use of human genes. He is the author/co-author of over 90 research articles in the biomedical field. Prior to Lupin, Kamboj worked with Xenon Pharmaceuticals Inc, Vancouver, and NPS Allelix, Canada. He did his doctorate from the University of Adelaide, Australia.
This person is not in any offices
Lupin
15 followers
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments.